Investing.com - Illumina (NASDAQ:ILMN) reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Illumina announced earnings per share of $0.57 on revenue of $1.16B. Analysts polled by Investing.com anticipated EPS of $0.6389 on revenue of $1.22B.
Illumina shares are down 40.22% from the beginning of the year and are trading at $183.08 , down-from-52-week-high.They are under-performing the S&P 500 which is down 11.72% from the start of the year.
Illumina shares lost 19.50% in after-hours trade after the report.
Illumina follows other major Healthcare sector earnings this month
Illumina's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar